Neurological outcome after cardiac arrest: A prospective study of the predictive ability of prognostic biomarkers neuron-specific enolase, glial fibrillary acidic protein, S-100B, and procalcitonin
dc.contributor.author | Ok G. | |
dc.contributor.author | Aydin D. | |
dc.contributor.author | Erbüyün K. | |
dc.contributor.author | Gürsoy C. | |
dc.contributor.author | Taneli F. | |
dc.contributor.author | Bilge S. | |
dc.contributor.author | Dinç Horasan G. | |
dc.date.accessioned | 2024-07-22T08:12:18Z | |
dc.date.available | 2024-07-22T08:12:18Z | |
dc.date.issued | 2016 | |
dc.description.abstract | Background/aim: Factors affecting neurological outcome and the usefulness of neuron-specific enolase (NSE), S-100B, glial fibrillary acidic protein (GFAP), and procalcitonin (PCT) in predicting neurological outcomes were assessed in patients who survived at least 24 h after cardiopulmonary resuscitation (CPR). Materials and methods: Thirty successfully resuscitated cardiac arrest patients were included in this prospective clinical study. The initial cardiac arrest rhythm, duration of CPR, return of spontaneous circulation time, administered doses of adrenaline, base excess, blood sugar, and hemodynamic parameters were recorded. Patients with Glasgow Outcome Scale (GOS) scores of 1–3 were defined as Group I and patients with GOS scores of 4–5 were defined as Group II. Serum NSE, GFAP, S-100B, and PCT levels were compared between the two groups shortly after CPR (hour 0) and at hours 12 and 24 of the postresuscitation period. Results: Serum S-100B was significantly higher (P = 0.009) in Group II immediately after CPR. Serum S-100B and NSE after CPR at hours 0, 12, and 24 were significantly lower in patients who survived to hospital discharge. Serum PCT at hours 12 and 24 and serum S-100B after CPR at 0, 12, and 24 h reached 94.7% sensitivity. Serum NSE, GFAP, S-100B, and PCT specificities were lower than 50%. Conclusion: In predicting neurological outcomes, serum S-100B has high sensitivity and low specificity immediately after CPR. © TÜBİTAK. | |
dc.identifier.DOI-ID | 10.3906/sag-1503-64 | |
dc.identifier.issn | 13000144 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/15978 | |
dc.language.iso | English | |
dc.publisher | Turkiye Klinikleri Journal of Medical Sciences | |
dc.rights | All Open Access; Bronze Open Access | |
dc.subject | Biomarkers | |
dc.subject | Calcitonin | |
dc.subject | Glial Fibrillary Acidic Protein | |
dc.subject | Heart Arrest | |
dc.subject | Humans | |
dc.subject | Phosphopyruvate Hydratase | |
dc.subject | Prognosis | |
dc.subject | Prospective Studies | |
dc.subject | S100 Calcium Binding Protein beta Subunit | |
dc.subject | biological marker | |
dc.subject | epinephrine | |
dc.subject | glial fibrillary acidic protein | |
dc.subject | glucose | |
dc.subject | neuron specific enolase | |
dc.subject | procalcitonin | |
dc.subject | protein S100B | |
dc.subject | biological marker | |
dc.subject | calcitonin | |
dc.subject | enolase | |
dc.subject | glial fibrillary acidic protein | |
dc.subject | protein S100B | |
dc.subject | adult | |
dc.subject | aged | |
dc.subject | Article | |
dc.subject | artificial ventilation | |
dc.subject | circulation time | |
dc.subject | clinical article | |
dc.subject | electrocardiography | |
dc.subject | enzyme linked immunosorbent assay | |
dc.subject | female | |
dc.subject | follow up | |
dc.subject | Glasgow outcome scale | |
dc.subject | heart arrest | |
dc.subject | heart rhythm | |
dc.subject | heart ventricle fibrillation | |
dc.subject | heart ventricle tachycardia | |
dc.subject | hospital discharge | |
dc.subject | human | |
dc.subject | male | |
dc.subject | mean arterial pressure | |
dc.subject | middle aged | |
dc.subject | prospective study | |
dc.subject | receiver operating characteristic | |
dc.subject | resuscitation | |
dc.subject | sensitivity and specificity | |
dc.subject | prognosis | |
dc.title | Neurological outcome after cardiac arrest: A prospective study of the predictive ability of prognostic biomarkers neuron-specific enolase, glial fibrillary acidic protein, S-100B, and procalcitonin | |
dc.type | Article |